









Markets
/
Stocks
/
nasdaq-tlx
/

Telix Pharmaceuticals Ltd

TLX

View Detailed Chart

13.050USD

-0.540-3.97%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Telix Pharmaceuticals Ltd

13.050

-0.540-3.97%

Overview Company Financials

Financials

Intraday

30m

Today

-3.97%

5 Days

-8.10%

1 Month

-18.79%

6 Months

-28.92%

Year to Date

-15.26%

1 Year

0.00%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts

STRONG BUY

Current Rating

20.047

Target Price

53.62%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Telix Pharmaceuticals Ltd

TLX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(0)

Buy(0)

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.454

Sell

RSI(14)

29.846

Sell

STOCH(KDJ)(9,3,3)

5.877

Oversold

ATR(14)

0.659

High Vlolatility

CCI(14)

-103.832

Sell

Williams %R

96.263

Oversold

TRIX(12,20)

-0.667

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

13.518

Sell

MA10

14.304

Sell

MA20

15.117

Sell

MA50

16.054

Sell

MA100

16.545

Sell

MA200

16.629

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical devices. It develops a portfolio of clinical and commercial stage products that addresses significant unmet medical needs in oncology and rare diseases. It operates a pipeline of theranostic radiopharmaceutical product candidates with a focus on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning. Its segments include commercial, product development, medical technologies, and manufacturing services. Its lead imaging product is gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix). Its other pipelines include TLX591, TLX592, TLX250, TLX101, TLX300, TLX66, TLX66-CDx, and TLX090, among others.

Ticker SymbolTLX

CompanyTelix Pharmaceuticals Ltd

CEOMr. Kevin Richardson

Websitehttps://telixpharma.com/